首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3189篇
  免费   171篇
  国内免费   55篇
医药卫生   3415篇
  2023年   34篇
  2022年   31篇
  2021年   137篇
  2020年   63篇
  2019年   119篇
  2018年   116篇
  2017年   94篇
  2016年   92篇
  2015年   91篇
  2014年   147篇
  2013年   142篇
  2012年   258篇
  2011年   250篇
  2010年   144篇
  2009年   120篇
  2008年   199篇
  2007年   205篇
  2006年   193篇
  2005年   184篇
  2004年   183篇
  2003年   119篇
  2002年   105篇
  2001年   49篇
  2000年   50篇
  1999年   38篇
  1998年   14篇
  1997年   15篇
  1996年   18篇
  1995年   18篇
  1994年   14篇
  1993年   11篇
  1992年   14篇
  1991年   10篇
  1990年   12篇
  1989年   7篇
  1988年   10篇
  1987年   9篇
  1986年   12篇
  1985年   6篇
  1984年   5篇
  1983年   9篇
  1982年   5篇
  1980年   4篇
  1979年   7篇
  1978年   4篇
  1976年   6篇
  1974年   11篇
  1973年   4篇
  1972年   5篇
  1970年   6篇
排序方式: 共有3415条查询结果,搜索用时 15 毫秒
1.
The association between asbestos exposure, mainly in occupational settings, and malignant mesothelioma has been well established; this has prompted several countries to establish mesothelioma epidemiologic surveillance programs often at the request of national agencies. This review compares currently existing mesothelioma registries worldwide to develop a concept model for a US real-time case capture mesothelioma registry. Five countries were identified with a mesothelioma specific registry, including Italy, France, UK, Australia, and South Korea. All, except the UK, used interviews to collect exposure data. Linkage with the national death index was available or was in future plans for all registries. The registries have limited information on treatment, quality of life, and other patient-centered outcomes such as symptoms and pain management. To thoroughly collect exposure data, “real-time” enrollment is preferable; to maximize the capture of mesothelioma cases, optimal coverage, and a simplified consent process are needed.  相似文献   
2.
3.
It is important to determine when to use and when to avoid calcineurin inhibitors (CNIs). CNIs are associated with kidney dysfunction in some, but not all, transplant recipients. CNI-sparing protocols have their own drug-specific limitations. Two major clinical series suggest the benefit of routine CNI-sparing approaches, but our review suggests weaknesses in both. Ongoing studies are needed to determine which subgroups of recipients will benefit from CNIs.  相似文献   
4.
5.
Perianal mucinous adenocarcinoma is a rare tumour which may be associated with long‐standing chronic perianal sepsis. Early diagnosis is challenging and is based on a high index of clinical suspicion and specific histological features. Definitive treatment is surgical, in the form of an abdomino‐perineal resection. We hereby describe a case of a perianal mucinous adenocarcinoma arising from long‐standing recurrent perianal fistula and complement this with a brief review of the literature pertaining in particular to the management of this condition.  相似文献   
6.
We compared three maintenance immunosuppressive regimens in a rapid discontinuation of prednisone protocol. From March 1, 2001, through December 31, 2003, 239 first and second kidney transplant recipients (166 LD; 73 DD) were randomized. All recipients were treated with Thymoglobulin; all received steroids intraoperatively and for 5 days postoperatively. Randomization was to cyclosporine-mycophenolate mofetil (n = 85); high-level tacrolimus (TAC) (8-12 ng/mL)-low-level sirolimus (SRL) (3-7 ng/mL) (n = 72); or low-level TAC (3-7 ng/mL)-high-level SRL (8-12 ng/mL) (n = 82). We found no difference at 24 months between groups in patient, graft, death-censored graft, or acute rejection-free graft survival, or in kidney function. Wound complications were more common in SRL-treated recipients (p = 0.02); we found no other differences between groups in complication rates. Our data suggest that excellent patient and graft survival and low rejection rates can be obtained using a variety of maintenance protocols without prednisone.  相似文献   
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号